Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:52:05.062Z.
Calculation as of: 2026-10-06T17:52:05.062Z.
Quote observation: 2026-10-06T17:50:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7de7752a9f7c92cf302168b3adc2b8952dbd3ee015c15fa7e623ade4200d4f53
EARNINGS YIELD
N/A
Market Cap
$786.00M
Earnings Yield
N/A
TTM Avg
0.49%
3Y Avg
4.33%
5Y Avg
4.33%
Market Cap
$842.48M
Earnings Yield
N/A
TTM Avg
0.29%
3Y Avg
0.29%
5Y Avg
0.29%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jade Biosciences, Inc. (JBIO) | $803.61M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $802.74M | 8.81% | 11.03% | 10.77% | 8.20% |
| Ardelyx, Inc. (ARDX)vs › | $810.26M | N/A | 0.51% | 0.51% | 0.51% |
| AdaptHealth Corp. (AHCO)vs › | $787.75M | N/A | 5.97% | 4.36% | 4.36% |
| Geron Corporation (GERN)vs › | $785.86M | N/A | 0.17% | 0.17% | 0.17% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $786.00M | N/A | 0.49% | 4.33% | 4.33% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $842.48M | N/A | 0.29% | 0.29% | 0.29% |
| Alumis Inc. (ALMS)vs › | $832.55M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $833.88M | N/A | N/A | N/A | N/A |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $833.66M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
